Sustained release formulations of venlafaxine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060246132A1
SERIAL NO

10544624

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to sustained release tablet formulations of venlafaxine. Kollidon SR proved to be an excellent sustained release agent for venlafaxine, that is an extremely soluble drug.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ACTAVIS GROUP HFREYKJAVIKURVEGI 76-78 HAFNARFIRDI 220

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Johannsson, Fjalar Reykjavik, IS 3 9

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation